Age Range
1 - 17
Trial Purpose
Izinjongo eziyinhloko zocwaningo ukuhlola ukuphepha nokubekezelelana, kanye ne-pharmacokinetics (PK) ye-sotatercept emavikini angu-24 okwelashwa ezinganeni ≥1 kuya eminyakeni engu-<18 ubudala ne-PAH World Health Organization (WHO) Iqembu 1 mayelana nokunakekelwa okujwayelekile (SoC). Ayikho i-hypothesis esemthethweni.
NATIONAL TRIAL REFERENCE NUMBER
I-NCT05587712
EudraCT
2022-000478-25
EU CT Number
2023-504861-22-00
When speaking to your doctor or clinical trial representative, please have the trial reference number available.
About The Study
Trial Phase
Trial start and end dates
- Actual study start date Januwari 19, 2023
- Estimated primary completion date Septhemba 21, 2028
- Estimated study completion date Septhemba 21, 2028